Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association

Journal of Rheumatology

Volumn 25, Issue 11, 1998, Pages 2140-2145

  Dababneh, Adele ^d   Gonzalez Gay, Miguel A ^b   Garcia Porrua, Carlos ^b   Hajeer, Ali ^d   Thomson, Wendy ^d   Ollier, William ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Hospital Xeral Calde

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d NONE

Author keywords

Giant cell arteritis; HLA genetics; Polymyalgia rheumatica

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; GIANT CELL ARTERITIS; HLA MATCHING; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; RISK FACTOR; SPAIN;

AGED; ALLELES; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; PHENOTYPE; POLYMYALGIA RHEUMATICA; REFERENCE VALUES; SEX CHARACTERISTICS; TEMPORAL ARTERITIS;

EID: 0031732199     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10 year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
2. Huston K, Hunder G, Lie J, Kennedy R, Elveback L. Temporal arteritis: a 25 year epidemiologic, clinical and pathologic study. Ann Intern Med 1978;88:162-7.
3. Calamia K, Hunder G. Clinical manifestation of giant cell arteritis. Rheum Dis Clin North Am 1980;6:389-403.
4. Bengtsson BA, Malmvall BE. The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Arthritis Rheum 1981;24:899-904.
5. Hunder GG, Bloch DA, Michael BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
6. Wilskie KR, Healey LA. Polymyalgia rheumatica, a manifestation of systemic giant cell arteritis. Ann Intern Med 1967;66:77-85.
7. Henderson DRF, Tribe CR, Dixon A St J. Synovitis in polymyalgia rheumatica. Rheum Rehabil 1975;14:244-50.
8. Cheung-Tei C, Shumacher HR Jr. Clinical and pathological studies of synovitis in polymyalgia rheumatica. Arthritis Rheum 1984;27:1107-17.
9. Healey LA, Sheets PK. The relation of polymyalgia rheumatica to rheumatoid arthritis. J Rheumatol 1989;15:750-2.
10. Cimmino MA, Caporali R, Montecucco CM, Rovida S, Baratelli E. A seasonal pattern in the onset of polymyalgia rheumatica. Ann Rheum Dis 1990;49:521-3.
11. Fessel WJ. Polymyalgia rheumatica, temporal arteritis and contact with birds. Lancet, 2:1249-50.
12. Bacon PA, Doherty SM, Zuckerman AJ. Hepatitis-B antibody in polymyalgia rheumatica. Lancet 1975;2:476-8.
13. Liang GC, Simkin PA, Hunder GG, Wilske KR, Healey LA. Familial aggregation of polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1974;17:19-24.
14. Granato JE, Abben RP, Stratford MW. Familial association of giant cell arteritis. Arch Intern Med 1981;141:115-7.
15. Ollier WER, MacGregor A. Genetic epidemiology of rheumatoid disease. Br Med Bull 1995;51:267-85.
16. Bignon JD, Ferec C, Barrier J, et al. HLA class II genes polymorphism in DR4 giant cell arteritis patients. Tissue Antigens 1988;32:254-8.
17. Haworth S, Ridgeway J, Stewart I, Dyer PA, Pepper L, Ollier W. Polymyalgia rheumatica is associated with both HLA-DRB1*0401 and DRB1*0404. Br J Rheumatol 1996;35:632-5.
18. Armstrong RD, Panayi GS, Welsh KI. Polymyalgia rheumatica and rheumatoid arthritis: similarity of HLA antigen frequencies. Arthritis Rheum 1984;27:1438-9.
19. Ollier B, Thomson W. Population genetics of rheumatoid arthritis. In: Dudlick B, editor. Rheumatic disease clinics of North America. Philadelphia: W.B. Saunders; 1992;741-59.
20. Labbe P, Flipo RM, Fajardy I, et al. HLA-DRB1 polymorphism in rhizomelic pseudo-polyarthritis and Horton disease. Rev Med Intern 1995;16:778-81.
21. Lowenstein MB, Bridgeford PH, Vasey FB, Germain BF, Espinoza LR. Increased frequency of HLA-DR3 and DR4 in polymyalgia rheumatica-giant cell arteritis. Arthritis Rheum 1983;26:925-7.
22. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. The HLA-DRB1 locus as a genetic component in giant cell arteritis - mapping of a disease-linked sequence motif to the antigen-binding site of the HLA-DR molecule. J Clin Invest 1992;90:2355-61.
23. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
24. Gonzalez-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo Spain is associated with low long term mortality. J Rheumatol 1997;24:2171-6.
25. Lie JT and the Members and Consultants of the American College of Rheumatology Subcommittee on classification of vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
26. Cohen MD, Ginsburgh WW. Polymyalgia rheumatica. Rheum Dis Clin North Am 1990;16:325-39.
27. Dababneh F, Farhan A, Payton A, Hajeer AH, Thomson W, Ollier WER. A comparative study of HLA-DR4 subtyping by SSCP versus sequence-based typing and inno-lipa strips [abstract]. Eur J Immunogenetics 1997;24:70.
28. Bignon JD, Fernandez-Vina MA, Chenean ML, et al. HLA DNA class II typing by PCR-SSOP: 12th International Histocompatibility experience. In: Charron D, editor. Proceedings of the Twelfth International Histocompatibility Workshop and Conference, Vol 1. Paris: EDK; 1997:21-5.
29. Cid MC, Ercilla G, Vilaseca J, et al. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Arthritis Rheum 1988;31:678-82.
30. Al-Jarallah KF, Buchanan WW, Sastny A, Singal DP. Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:529-31.
31. Guerne PA, Salvi M, Seitz M, et al. Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. J Rheumatol 1997;24:671-6.
32. Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy. Arthritis Rheum 1991;31:351-6.
33. Weyand CM, Hunder NNH, Hicok KC, Hunder GG, Goronzy JJ. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis. Arthritis Rheum 1994;37:514-20.
34. Healey LA. The spectrum of polymyalgia rheumatica. Clin Geriatr Med 1988;4:323-31.
35. Richardson JE, Gladman DD, Adel FAM, Keystone EC. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome. Arthritis Rheum 1987;30:1293-7.
36. Uddhammar A, Nilssonsojka B, Rantapaa-Dahlqvist S. HLA antigens in polymyalgia rheumatica in Northern Sweden. Clin Rheumatol 1996;15:486-90.
37. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy-proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. Arthritis Rheum (submitted).
38. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. HLA class II and TNF haplotypes in RA patients from N.W. Spain. Tissue Antigens (submitted).
39. Yelamos J, Garcia-Lozanor R, Moreno I, et al. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum 1993;36:811-4.
40. De juan MD, Belmonte I, Barado J, et al. Differential association of HLA-DR antigens with rheumatoid arthritis in Basques: high frequency of DR1 and DR10 and lack of association with HLA-DR4 or any of its subtypes. Tissue Antigens 1994;43:320-3.
41. Bosch-Gimpera P. Prehistory of Europe. Madrid: Istmo; 1975.
42. Kruta V. The Celts. Madrid: Edaf; 1981.
43. MacGregor AJ, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/0404 genotype and rheumatoid arthritis: increased association in men, young age at onset and disease severity. J Rheumatol 1995;22:1032-6.